Halper Sadeh Investigates Priority Technology's $8.05-a-Share Sale to CEO-Led Group

Halper Sadeh LLC is investigating the sale of Priority Technology Holdings, Inc. to an investor group led by Thomas Priore, the company's Chairman and Chief Executive Officer, for $8.05 per share in cash. The investor rights law firm announced the investigation in a Business Wire release dated October 31, 2026.

Halper Sadeh's Three Questions for the Priority Board

Halper Sadeh said the investigation concerns whether Priority Technology and its board violated federal securities laws or breached fiduciary duties by failing to obtain the best possible price for shareholders, conduct a fair sales process free of conflicts of interest, and disclose all material information shareholders need to evaluate the transaction. The release states that insiders may stand to receive substantial financial benefits not available to ordinary shareholders, and that the proposed transaction may contain terms that could limit superior competing offers.

Priority Technology is the target of the $8.05-a-share cash sale to the Priore-led group. Levi & Korsinsky, LLP notified stockholders on October 9, 2026 and again on October 30, 2026 of its own investigation into the fairness of Priority Technology's acquisition by its largest stockholder, Thomas C. Priore, according to PR Newswire.

"Insiders may stand to receive substantial financial benefits not available to ordinary shareholders," the firm said in the release.

Halper Sadeh's Recovery Record

Halper Sadeh was founded in New York in 2015 as a specialized investor rights law firm operating on a contingency-fee model for securities fraud and corporate misconduct litigation, according to akta.pro company records. The same records list recoveries including $20 million in In re Galena Biopharma, Inc., Securities Litigation (D. Or.) and $23.5 million in Thomas v. Magnachip Semiconductor Corp. (N.D. Cal.). The firm's leadership includes founding partners Zachary Halper and Daniel Sadeh, and the release directs shareholders to contact Daniel Sadeh or Zachary Halper.

Halper Sadeh's Earlier Deal Probes

Halper Sadeh announced on August 24, 2026 that it was investigating Werewolf Therapeutics, Beazer Homes USA, MarketAxess Holdings and CBIZ for potential securities law violations and fiduciary duty breaches, according to FinancialContent Business Page. On August 28, 2026, the firm said it was investigating VREX, BWMN, NATH and SYBX for possible securities law violations and fiduciary duty breaches, the same outlet reported. On September 8, 2026, it said it was investigating Bio-Techne's sale to Merck, Colony Bankcorp's merger with First Reliance and Auddia's merger with Thramann for potential securities law violations.

What Halper Sadeh Says Shareholders Can Do

Halper Sadeh said it may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders. The firm said it would handle any matter on a contingent fee basis, with clients not responsible for out-of-pocket payment of legal fees or expenses.